Multidrug Idebenone/Naproxen Co-loaded Aspasomes for Significant in vivo Anti-inflammatory Activity.

Authors:
d'Avanzo N; Cristiano MC; Di Marzio L; Bruno MC; Paolino D and 2 more

Journal:
ChemMedChem

Publication Year: 2022

DOI:
10.1002/cmdc.202200067

PMCID:
PMC9310947

PMID:
35194952

View on PubMed View on PMC View Publisher
Journal Information

Full Title: ChemMedChem

Abbreviation: ChemMedChem

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Exploring Covalent Bond Formation at Tyr-82 for Inhibition of Ral GTPase Activation.
Landgraf AD; Yeh IJ; Ghozayel MK and 3 more (2023) - Transparency Score: 3/6
2-Amino-4-aryl-5-oxo-4,5-dihydropyrano[3,2-c]chromene-3-carbonitriles with Microtubule-Disruptive, …
Köhler LHF; Reich S; Begemann G and 2 more (2022) - Transparency Score: 3/6
7H-Pyrrolo[2,3-d]pyrimidine-4-amines as Potential Inhibitors of Plasmodium falciparum Calcium-Depen…
Seanego TD; Chavalala HE; Henning HH and 4 more (2022) - Transparency Score: 4/6
8-Hydroxy-1,6-naphthyridine-7-carboxamides as Inhibitors of Human Cytomegalovirus pUL89 Endonucleas…
Jung E; Majima R; Edwards TC and 3 more (2022) - Transparency Score: 3/6
Advanced Pyrrolidine-Carbamate Self-Immolative Spacer with Tertiary Amine Handle Induces Superfast …
Dal Corso A; Frigoli M; Prevosti M and 5 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare no conflict of interest."

Evidence found in paper:

"This work was supported in part by Ministero dell‘Università e della Ricerca (MUR) [FAR 2018 (D56C18000780005), FAR 2019 (D54I19002790005)] to C. C. and L. D. M. Open Access Funding provided by Universita degli Studi Gabriele d'Annunzio Chieti Pescara within the CRUI‐CARE Agreement."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025